Helen Chen
Greater China Managing Partner at L.E.K. Consulting Limited
Helen Chen is the Greater China managing partner of L.E.K. Consulting based in Shanghai, and a winner of the prestigious Global Leaders in Consulting for 2019 award from Consulting Magazine. She sat on L.E.K.’s Global Leadership Team, the firm’s governing board, from 2012 to 2016, and served as the head of L.E.K.’s China practice from 2011 to 2018 and Asia life sciences practice from 2015 to 2019. Helen has over 30 years of consulting and industry experience in the U.S. and Asia, and has resided in China since 2000.
Helen is the head of L.E.K.’s China healthcare practice and a board member of L.E.K.’s Asia Pacific Life Sciences Centre of Excellence, supported by Singapore’s Economic Development Board. She has extensive case work and industry experience covering the full biopharmaceutical and medtech value chain, ranging from early research services to post-market product positioning and sales force effectiveness. In China, she has developed commercial strategies for international biopharmas and medtechs, investment thesis for financial investors, business plans for domestic startups and policy analyses for industry associations.
Helen is a frequent speaker and author on the opportunities and issues in the China healthcare and life sciences, and has been quoted by publications including BioCentury, BioWorld, In Vivo, Wall Street Journal, South China Morning Post, Financial Times and Forbes Asia.
Prior to joining L.E.K., Helen was an associate director of finance at Genentech (now Roche) and a sales planner at Abbott Laboratories (now AbbVie). She was on the Board of Pharmaceutical Management Sciences Association from 1995 to 1997.
Helen received her A.B. cum laude in applied mathematics from Harvard University.